Intuitive Surgical, Inc. (ETR:IUI1)

Market Cap	172.85B
Revenue (ttm)	8.19B
Net Income (ttm)	2.34B
Shares Out	n/a
EPS (ttm)	6.44
PE Ratio	73.83
Forward PE	60.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40
Average Volume	305
Open	489.45
Previous Close	486.10
Day's Range	489.45 - 491.40
52-Week Range	341.55 - 594.40
Beta	n/a
RSI	61.59
Earnings Date	Jan 21, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1995
• Employees: 15,638
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: IUI1

Financial Performance

In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.

Financial numbers in USD